Have a feature idea you'd love to see implemented?
Let us know!
CERS Cerus Corp
Price (delayed)
$1.67
Market cap
$310.14M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.11
Enterprise value
$384.83M
Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies
Highlights
The company's net income has surged by 60% YoY and by 18% QoQ
CERS's EPS has surged by 59% year-on-year and by 15% since the previous quarter
The gross margin has declined by 3.7% year-on-year
Cerus's debt has increased by 3.1% YoY
Key stats
What are the main financial stats of CERS
Market
Valuations
Earnings
Shares outstanding
185.72M
Market cap
$310.14M
Enterprise value
$384.83M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.79
Price to sales (P/S)
1.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.94
Revenue
$197.91M
EBIT
-$10.51M
EBITDA
-$5.66M
Free cash flow
-$10.61M
Per share
Balance sheet
Liquidity
EPS
-$0.11
Free cash flow per share
-$0.06
Book value per share
$0.29
Revenue per share
$1.07
TBVPS
$1.02
Total assets
$189.54M
Total liabilities
$135.26M
Debt
$97.9M
Equity
$53.49M
Working capital
$86.27M
Debt to equity
1.83
Current ratio
2.59
Quick ratio
1.87
Net debt/EBITDA
-13.19
Margins
Efficiency
Dividend
EBITDA margin
-2.9%
Gross margin
60.5%
Net margin
-10%
Operating margin
-6%
Return on assets
-10.4%
Return on equity
-38.5%
Return on invested capital
-5%
Return on capital employed
-7.8%
Return on sales
-5.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CERS stock price
How has the Cerus stock price performed over time
Intraday
0.6%
1 week
-7.22%
1 month
-0.6%
1 year
-1.18%
YTD
-22.69%
QTD
-4.02%
Financial performance
How have Cerus's revenue and profit performed over time
Revenue
$197.91M
Gross profit
$119.78M
Operating income
-$11.8M
Net income
-$19.73M
Gross margin
60.5%
Net margin
-10%
Cerus's operating margin has surged by 73% YoY and by 28% QoQ
CERS's operating income has surged by 71% year-on-year and by 27% since the previous quarter
Cerus's net margin has surged by 63% YoY and by 19% QoQ
The company's net income has surged by 60% YoY and by 18% QoQ
Growth
What is Cerus's growth rate over time
Valuation
What is Cerus stock price valuation
P/E
N/A
P/B
5.79
P/S
1.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.94
CERS's EPS has surged by 59% year-on-year and by 15% since the previous quarter
CERS's price to book (P/B) is 39% lower than its 5-year quarterly average of 9.5 and 14% lower than its last 4 quarters average of 6.7
CERS's equity is up by 11% year-on-year and by 8% since the previous quarter
The stock's price to sales (P/S) is 71% less than its 5-year quarterly average of 5.3 and 13% less than its last 4 quarters average of 1.8
CERS's revenue is up by 7% year-on-year
Efficiency
How efficient is Cerus business performance
The ROIC has soared by 78% YoY and by 30% from the previous quarter
CERS's return on sales has surged by 76% year-on-year and by 30% since the previous quarter
CERS's return on equity has surged by 56% year-on-year and by 20% since the previous quarter
Cerus's return on assets has surged by 56% YoY and by 16% QoQ
Dividends
What is CERS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CERS.
Financial health
How did Cerus financials performed over time
CERS's total assets is 40% greater than its total liabilities
The quick ratio rose by 43% year-on-year and by 4.5% since the previous quarter
Cerus's current ratio has increased by 38% YoY and by 3.2% QoQ
Cerus's debt is 83% higher than its equity
CERS's equity is up by 11% year-on-year and by 8% since the previous quarter
Cerus's debt to equity has decreased by 8% QoQ and by 7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.